Cargando…
A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD
BACKGROUND: NS2359 is a potent reuptake blocker of noradrenalin, dopamine, and serotonin. The aim of the study was to investigate the efficacy, safety and cognitive function of NS2359 in adults with a DSM IV diagnosis of ADHD. METHODS: The study was a multi-centre, double-blind, randomized placebo-c...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442604/ https://www.ncbi.nlm.nih.gov/pubmed/18554401 http://dx.doi.org/10.1186/1744-9081-4-24 |